Skip to content

The effect of transcranial magnetic stimulation (rTMS) on central sensitization in patients with chronic low back pain and its brain network mechanisms.

The effect of transcranial magnetic stimulation (rTMS) on central sensitization in patients with chronic low back pain and its brain network mechanisms.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077731
Enrollment
Unknown
Registered
2023-11-17
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic low back pain

Interventions

sham stimulation group:sham rTMS combined with exercise
intervention group1:high-frequency (HF) rTMS of the left primary motor cortex (M1) combined with exercise
intervetion group2:high-frequency (HF) rTMS of the left dorsolateral prefrontal cortex (DLPFC) combined with exercise
healthy control group:no intervention

Sponsors

Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria for patients with chronic low back pain (CLBP) are as follows: 1) a clinical diagnosis of CLBP with persistent pain = 3 months or intermittent pain >6 months; 2) aged 18-65 years; 3) score of at least 3 on the Visual Analogue Scale (VAS) in the preceding week; 4) right-hand dominance; 5) score of at least 26 on the Montreal Cognitive Assessment (MoCA), literacy or no difficulties in communication; 6) no pain treatment within the past 3 months; and 7) no contraindication for MRI (e.g., claustrophobia, pacemaker, or metal implants in the body) . The inclusion criteria for healthy controls these participants are as follows: 1) no symptoms of back pain for the past 6 months; 2) aged 18-65 years; 3) right-hand dominance;4) no symptoms of low back pain or other pain disorders such as migraine and fibromyalgia.

Exclusion criteria

Exclusion criteria: The exclusion criteria were as follows: 1) low back pain with specific causes (e.g., vertebral fracture, or severe osteoporosis); 2) any psychiatric disorders that require current pharmacotherapy; 3) a history of spine/hip/lower limb joint surgery or injury, or any plan of surgery in the next year. 4) menstrual pain, postpartum low back pain, pregnancy or any plan of pregnancy; 5) neurological diseases (e.g., traumatic brain injury or epilepsy), cardiocerebrovascular disease, hypertension with blood pressure higher than 160/100 mmHg; 6) presence of cancer, significant unexplained weight loss, any sign of intracranial lesions during MRI scans; 7) endocrine disorders, drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
VAS ;P40 pressure pain threshold;central sensitization inventory ;

Secondary

MeasureTime frame
Montreal Cognitive Assessment;Digit Span Test;Stroop test;Color Trails Test;Pittsburgh Sleep Quality Index;Insomnia Severity Index;Hamilton Depression Scale;Hamilton Anxiety Sca;Pain Catastrophizing Scale;Oswestry Disability Inde;Short-Form McGill Pain Questionnaire ;Tampa Scale of Kinesiophobia;Fear-avoidance belief questionnaire;Beck Depression Inventory;side effects;

Countries

China

Contacts

Public ContactXiquan Hu

The Third Affiliated Hospital of Sun Yat-sen University

huxiquan@mail.sysu.edu.cn+86 189 2210 2910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026